SCHEMBL22947128

SCHEMBL22947128

c1ccc(-c2c3ccccc3c(-c3ccc4c(c3)oc3cccc(-c5cccc6ccccc56)c34)c3ccccc23)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.38
▸ KDM4E B2RXH2 3/20 0.38
▸ HSD17B10 Q99714 3/20 0.38
▸ MAPT P10636 3/20 0.38
▸ TDP1 Q9NUW8 2/20 0.38
▸ L3MBTL1 Q9Y468 2/20 0.38
▸ ATM Q13315 2/20 0.38
▸ HPGD P15428 2/20 0.38
▸ TP53 P04637 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ NFKB1 P19838 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ NFKB2 Q00653 1/20 0.38
▸ RELA Q04206 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ GPR84 Q9NQS5 1/20 0.36
▸ PSD A5PKW4 1/20 0.36
▸ CYP1A2 P05177 2/20 0.36
▸ CYP1A1 P04798 1/20 0.36
▸ FYN P06241 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23427655 0.93 PSD (0.38) ALDH1A1KDM4EHSD17B10MAPTTDP1
SCHEMBL23428151 0.93 PSD (0.38) ALDH1A1KDM4EHSD17B10MAPTTDP1
SCHEMBL23427652 0.92 CA12 (0.39) ALDH1A1KDM4EHSD17B10MAPTTDP1
SCHEMBL23428150 0.92 CA12 (0.39) ALDH1A1KDM4EHSD17B10MAPTTDP1
SCHEMBL27011442 0.91 PSD (0.38) ALDH1A1KDM4EHSD17B10MAPTTDP1
SCHEMBL22915543 0.91 PIM1 (0.40) ALDH1A1KDM4EHSD17B10MAPTTDP1
SCHEMBL24332753 0.91 MCL1 (0.40) ALDH1A1KDM4EHSD17B10MAPTTDP1
SCHEMBL20109952 0.89 PLA2G2A (0.39) ALDH1A1KDM4EHSD17B10MAPTTDP1
SCHEMBL23427213 0.89 ENPP3 (0.38) ALDH1A1KDM4EHSD17B10MAPTTDP1
SCHEMBL23427212 0.89 PSD (0.40) ALDH1A1KDM4EHSD17B10MAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240023359-A1 ORGANIC LIGHT-EMITTING DEVICE COMPRISING NOVEL ORGANIC COMPOUND IN EMISSION LAYER SFC CO., LTD. (KR) 2024-01-18 — — US disclosed
US-20240023359-A1 ORGANIC LIGHT-EMITTING DEVICE COMPRISING NOVEL ORGANIC COMPOUND IN EMISSION LAYER SFC CO., LTD. (KR) 2024-01-18 — — US disclosed
US-20230371376-A1 POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME SFC CO., LTD. (KR) 2023-11-16 — — US disclosed
US-20230371376-A1 POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME SFC CO., LTD. (KR) 2023-11-16 — — US disclosed
EP-4119634-B1 POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME SFC CO LTD (KR) 2023-09-20 — — EP disclosed
EP-4119634-A1 POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME SFC Co., Ltd. (KR) 2023-01-18 — — EP disclosed
US-11482676-B2 Light emitting diode including boron compound SFC CO., LTD. (KR) 2022-10-25 — — US disclosed
US-20220123219-A1 COMPOUND FOR ORGANIC LIGHT EMITTING ELEMENT, AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME AND HAVING LONG LIFESPAN SFC CO., LTD. (KR) 2022-04-21 — — US disclosed
EP-3792989-A1 ORGANIC LIGHT EMITTING DIODE INCLUDING BORON COMPOUNDS SFC Co., Ltd. (KR) 2021-03-17 — — EP disclosed
US-20210036233-A1 LIGHT EMITTING DIODE INCLUDING BORON COMPOUND SFC CO., LTD. (KR) 2021-02-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230371376-A1 POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME PPOX, MAP1LC3A, VDAC2 ALDH1A1 1243/4885KDM4E 1900/4885HSD17B10 2364/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback